The global DNA sequencing market is anticipated to grow at a CAGR of around 19.9% during the forecast period 2020 to 2027 and to reach around US$ 37.6 Bn by 2027.

Market Dynamics

High government spending on development of present healthcare infrastructure, increasing R&D activities related to development of DNA analysis technology, coupled with innovative product offerings by major players are factor expected to drive the growth of global market. In addition, increasing prevalence of chronic diseases across the globe, rising demand for advanced diagnostic solutions is resulting in resulting in demand for DNA sequencing solutions due to its applicability in diagnostics and biomarkers & cancer is another important factor expected to support the growth of target market.

Players are investing high for product development along with innovative product offerings in order to attract new customers is another important factor expected to further support the growth of target market.

• In 2020, Nebula Genomics a personal genomics company launched direct-to-consumer whole genome sequencing. This is expected to help the company to enhance the product portfolio and enhance the profit ratio.
• In 2020, Agilent Technologies Inc. launched SureSelect XT HS2 DNA Kit a product designed to address key challenges that laboratories encounter when preparing DNA sequencing libraries for their research. This is expected to help the company to enhance the product portfolio.

In addition, players approach towards strategic business expansion through partnerships and agreements is another factor expected to further support the growth of target market.

• In 2020 Agilent Technologies signed a co-marketing agreement with Mission Bio in order to drive adoption of Mission Bio’s Tapestri Platform a multi-omic device to analyze both DNA and protein at the single-cell level.
• In 2018, Agilent Technologies Inc acquired Lasergen, Inc. an emerging biotechnology company focused on research and development of innovative technologies for DNA sequencing. This acquisition is expected to help the company to enhance the business presence and increase the profit.

However, factor such as rising concern related to data security and high cost of equipments are expected to hamper the growth of global DNA sequencing market. In addition, lack of skilled expertise is another important factor expected to further support the growth of target market.

High investment for technological advancements and major player’s inclination towards developing countries in order to track the untapped market are factors expected to create new opportunities for players operating in the target market over the forecast period.

DNA Sequencing Market Segment Analysis, 2019

The global DNA sequencing market is further segmented into product, application, technology, and end user. The technology segment is further bifurcated into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing, chain termination sequencing, and nanopore sequencing. Among end use the biotechnology companies segment is expected to account for significant revenue share in the global market.

Segment Analysis by Region

The market in North America is expected to account for significant revenue share owing to high patient pool suffering from chronic diseases and rising demand for advanced diagnostic solutions. In addition, increasing government spending on development of healthcare sector, high investment by major players for R&D activities, coupled with innovative product offerings are among other factors expected to further support the growth of regional market.

Asia Pacific is expected to witness faster growth in the near future owing to increasing government spending on development healthcare infrastructure. In addition, developing regulatory scenario and major player’s inclination towards emerging economies in order to increase the business presence is another important factor expected to further support the growth of target market.

Competitive Landscape

The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.

Report coverage

Market	Global DNA Sequencing Market
Analysis Period	2016 – 2027
Base Year	2019
Forecast Data	2020 – 2027
Market Stratification	Product, Application, Technology, End User and Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

The market research study on “DNA Sequencing Market (Product: Consumable, Instrument, and Service; Application: Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others; Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing; End Use: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and  Hospitals & Clinics) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027”, offers a detailed insights on the global DNA sequencing market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global DNA sequencing market segment by product, application, technology, end user and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global DNA sequencing market size and segment markets by product, application, technology, end user and geography along with the information on companies operating in the market. The DNA sequencing market analysis is provided for major regional market including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report. The players profiled in the report Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Bio-Rad Laboratories, Inc., Eurofins Scientific, Gatc Biotech AG, DNASTAR, Inc., Biomatters Ltd., New England Biolabs, Inc., and Myriad Genetics, Inc.

Market Segmentation

Market By Product

• Consumable
• Instrument
• Service
  
  

Market By Technology

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Single-molecule Real-time Sequencing
• Chain Termination Sequencing
• Nanopore Sequencing
  
  

Market By Application

• Diagnostics
• Biomarkers & Cancer
• Reproductive Health
• Personalized Medicine
• Forensics
• Others
  
  

Market By End Use

• Academic & Government Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Hospitals & Clinics
  
  

Market By Region

North America

• US
• Canada

Europe

• UK
• Germany
• France
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest if Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Meddle East & Africa

TABLE OF CONTENT